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Abstract The aim of this study was to compare perceived
barriers to and the most preferred age for successful transition
to adult health care between young people with chronic dis-
orders who had not yet transferred from pediatric to adult
health care (pre-transfer) and those who had already trans-
ferred (post-transfer). In a cross-sectional study, we compared
283 pre-transfer with 89 post-transfer young people, using a
28-item questionnaire that focused on perceived barriers to
transition and beliefs about the most preferred age to transfer.
Feeling at ease with the pediatrician was the most impor-
tant barrier to successful transition in both groups, but
was rated significantly higher in the pre-transfer compared
to the post-transfer group (OR=2.03, 95 %CI 1.12–3.71).
Anxiety and lack of information were the next most
important barriers, rated equally highly by the two groups
(OR=0.67, 95 %CI 0.35–1.28 and OR=0.71, 95 %CI
0.36–1.38, respectively). More than 80 % of the respon-
dents in both groups reported that 16–19 years was the
most preferred age to transfer; more than half of all the
respondents reported 18–19 years and older as the most
preferred age. Conclusion: Better transition planning
through the provision of regular and more detailed infor-
mation about adult health-care providers and the transition
process could reduce anxiety and contribute to a more
positive attitude to overcome perceived barriers to transi-
tion from young people’s perspective. Young people’s
preferences about transferring to adult health care provide
a challenge to those children’s hospitals that transfer to
adult health care at a younger age.
Keywords Adolescence . Young adults . Chronic disease .
Transition toadulthealthcare .Qualityhealthcare .Adolescent
friendly health care
Abbreviations
AHC Adult health care
Post-transfer Sample of young people who had transferred
from pediatric to adult health care
Pre-transfer Sample of young people who had not yet
transferred from pediatric to adult health care
Introduction
Consensus statements about transition to adult health care
(AHC) provide expert guidance about how best to support
young people with chronic disorders during the transition
process [2, 5, 34]. However, there is evidence that many
young people continue to find transfer to AHC difficult [20,
23, 31, 38, 47, 48]. For example, a retrospective review of the
medical records of 14 recently transferred pediatric liver
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transplant recipients showed poorer adherence after transfer to
AHC [3]. Callahan et al. reported significant changes in
ambulatory health care during transition to adulthood with a
higher proportion of emergency department visits for young
adults 19–24 years of age compared to adolescents aged 13–
18 years [9]. In a recent study of adolescents and parents prior
to transfer to AHC, we showed that anxiety and lack of
information about AHC were among the most frequently
reported barriers to successful transition and that a majority
of adolescents who had not yet transferred to AHC perceived
the ages of 18–19 years and even older as the most preferred
age to transfer [35].
It can be argued, however, that the predominant focus of
adolescents’ perceptions prior to their transfer to AHCmay be
influenced by the emotional challenge of the upcoming trans-
fer. A different perspective may be gained from young people
after they have transferred to AHC. Few studies have
approached this in a systematic manner however, with the
published literature characterized by small sample sizes and/
or a disease-specific approach [4, 7, 11, 16, 28, 43, 44]. For
example, Tuchman et al. reported fears of adolescents with
chronic illness before transition (n=22), but only six partici-
pants had transferred to AHC during the 18-month survey
period which does not allow conclusions to be drawn about
the young people’s view after transfer [43]. Boyle et al. surveyed
60 patients with cystic fibrosis prior to and after transfer to AHC
[7]. They showed that the two areas of greatest concern prior to
transfer were potential exposure to infection and having to leave
their previous caregivers. They also showed significantly lower
levels of concern when the adult cystic fibrosis team was intro-
duced prior to transfer to AHC. The fact that anxiety about
exposure to infection was such a high concern in these adoles-
cents with cystic fibrosis shows the value of disease-specific
transition surveys. However, these concerns would not be gen-
eralizable to other conditions. Therefore, in addition to disease-
specific surveys, there is also a need for studies that provide a
broader picture across different conditions.
In this cross-sectional study, we set out to compare what
young people with various chronic health conditions, prior to
and after transfer to AHC, perceive as the most important
barriers to successful transition and what they think is the
most preferred age to transfer. This comparison aimed to
examine whether perceptions of adolescents prior to transfer
may be influenced by their upcoming transfer and modified by
their experiences after transfer.
Methods
We recruited young people with chronic disorders aged 14–
25 years who had not yet transferred to AHC (pre-transfer)
and those in the same age range who had transferred during
the 2 years preceding the study (post-transfer). Data were
collected from patients attending (pre-transfer) or having
attended (post-transfer) seven subspecialty clinics at two uni-
versity children’s hospitals in Switzerland, including cardiol-
ogy, endocrinology (diabetes only), nephrology, neurology,
pulmonology (cystic fibrosis only), gastroenterology, and
rheumatology. These subspecialties were chosen because of
their large numbers of long-term patients with chronic disor-
ders. In pulmonology, only patients with cystic fibrosis were
chosen, as for patients with asthma, it is not always possible in
middle adolescence to knowwho will need ongoing treatment
by adult specialists. There was no consistent approach to
transition to AHC among these programs; different ap-
proaches were utilized by the different clinical programs.
A 28-item questionnaire (29 items for post-transfer group)
was sent to all patients of the above-listed subspecialties by
postal mail (detailed methodology published previously [35]).
The item selection of the questionnaire development included
a literature search, expert opinion, and focus group interviews
with adolescents with chronic disorders. The questionnaire
was designed as a descriptive tool for this specific purpose
with content validity having been assessed as part of the
questionnaire development process. The response options
were designed to suit the purpose of this study, with Likert
scale response options offered where appropriate. Within the
pre- and post-questionnaires, a set of 24 core items enabled
comparison between the pre-transfer and the post-transfer
groups. Self-perceived health status, rate of school/work ab-
senteeism, and hospitalization rates during the last 12 months
were used as indicators of disease severity. Two waves of
reminder letters were mailed. The questionnaires were com-
pleted anonymously. Exclusion criteria were if the patient did
not have appropriate language skills (German or French), had
cognitive disability, was younger than 14 or older than
25 years, and if the patient no longer perceived that they
suffered from a chronic disorder. Consent was obtained from
patients as well as their parents for those younger than 18 years
of age. Ethics approval was obtained from the regional ethics
committees of the two university children’s hospitals.
Data were analyzed using SPSS 19.0 (SPSS Inc., Chicago).
Some item responses were dichotomized, depending on the
question under investigation. For example, the item “most
important barrier” consisted of a list of several potentially
important barriers (derived by the item selection process) with
each response dichotomized into yes (most important barrier)
or no (not the most important barrier). Statistical analysis
included frequency analysis for descriptive comparison of
pre- and post-transfer data, applying t test for continuous
variables and Pearson’s chi-square for categorical variables.
The analysis of the outcome variables “most important bar-
riers” and “most preferred age to transfer” included logistic
regression analysis for dichotomous outcomes and multino-
mial regression analysis for nondichotomous categorical/
ordinal outcomes. Multivariate analyses were adjusted for
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gender, congenital disorder, health status, recruiting hospital,
and specialty.
Within the survey, we differentiated the terms transfer and
transition. Transfer referred to the event of geographically or
physically transferring from pediatric to adult health care (e.g.,
most preferred age to transfer to adult health care). The term
transition was used when referring to the process of transition
or if the transfer was to be seen as part of this transitional
process [6, 39] (e.g., barriers to transition). Within this paper,
when citing individual studies, we have used the term in
accordance with how it was used in each paper. Transition
was defined as successful if the transfer to AHC had occurred
and the patient felt comfortable with treatment in AHC, as
reported by the patient.
Results
In the pre-transfer group, 298 patients agreed to participate in
the study (participation rate 62 %). Of these, 15 participants
were excluded from the study, mainly because of language
difficulties and because four patients were not yet 14 years
old. A total of 283 pre-transfer patients were included in the
final analysis. In the post-transfer group, 92 patients completed
the questionnaire (participation rate 54 %). Of these, three
patients were excluded from the final analysis because of being
older than 25 years, yielding a total of 89 post-transfer patients.
In both pre-transfer and post-transfer groups, the main reasons
for not participating were lack of interest and the patient’s
perception of not suffering from a chronic disorder anymore.
The mean age was 16.3 (2.2)years in the pre-transfer group
and 19.7 (2.3)years in the post-transfer group. Pre- and post-
transfer participants did not differ with regard to gender, hos-
pital, rate of congenital disorders, and severity of disease (see
Table 1). While all the pre-transfer patients were treated at one
or other of the recruiting pediatric hospitals, 23.6% of the post-
transfer patients consulted their AHC specialist in his or her
private practice. In the pre-transition group, all the patients had
seen a family doctor as well as their pediatric specialist at least
once during the last 12 months and 59 % of them had seen the
pediatric specialist three times or more often during the last
12 months. In contrast, in the post-transfer group, 48.3 %
reported that they had not seen their family doctor during the
last 12months, and 22.5% said that they had not seen the adult
specialist at all during the last 12 months. With regard to the
doctor-patient relationship, 91.9 % of the pre-transfer group
indicated that they felt very much or at least quite at ease with
their pediatric specialist, while in the post-transfer group, 73 %
said that they felt at ease with their adult specialist.
Fifty-one percent of the pre-transfer young people indicat-
ed that their pediatrician had ever talked to them about the
transition to AHC. In the post-transfer group, 10 % of the
respondents recalled this to have happened before the age of
16 years and 38.2 % reported that the first talk about transition
was at 16–17 years and 25.8 % at 18–19 years of age. Mean
age at time of transfer was 18.1±2.3 years, and 72 % felt very
much or quite ready to transfer at the time they transferred.
Seventy-nine percent of the post-transfer young people said
that the transfer to AHC was very easy or quite easy for them
to manage, and 50.5 % felt very well or quite well supported
during the transfer to AHC.
Feeling at ease with the pediatrician was the most impor-
tant barrier to transfer, reported by 48 % of the pre-transfer
group and 32 % of the post-transfer group. Yet, the odds that
young people reported feeling at ease with the pediatrician as
the most important barrier were two times higher for the pre-
transfer group (OR=2.03, 95 %CI 1.12–3.71). Anxiety and
lack of information were rated as similarly important in both
groups (OR=0.67, 95 %CI 0.35–1.28 and OR=0.71, 95 %CI
0.36–1.38, respectively). Participants were given the opportu-
nity to provide additional information on what contributed to
their anxiety: the main reasons mentioned were the potentially
different therapies in AHC, lack of information, concerns
about loss of information about their condition, and nonspe-
cific anxieties about AHC. In the pre-transition group, there
was a statistically significant correlation between age and
perceived lack of information (Spearman’s rho=0.15, p=
0.01), but not with anxiety (Spearman’s rho=0.02, p=0.71).
In the post-transition group, there was neither a statistically
significant correlation between age at transition and lack of
information (Spearman’s rho=−0.16, p=0.16) nor with anxi-
ety (Spearman’s rho=−0.13, p=0.25). Parents’ preference for
ongoing treatment by the pediatric team was perceived as the
most important barrier by 1 % of the pre-transfer group and
9 % of the post-transfer young people (OR=0.15, 95 %CI
0.04–0.58). A small number of respondents (6 pre-transfer, 4
post-transfer) cited other reasons that were not comparable
because of only being relevant for one or other group (e.g.,
loss of information of AHC provider after transfer). Four post-
transfer respondents indicated that no particular barrier was
the most important.
Eighteen to 19 years was the most frequently identified
preferred age to transfer to AHC, rated by 52 % of the pre-
transfer group (see Table 2). The post-transfer group equally
rated 16–17 years (43 %) and 18–19 years (40 %). Of the pre-
transfer and post-transfer respondents, 3.7 and 5.7 % reported
below 16 years as the most preferred age to transfer, while
14.2 % of the pre-transfer group and 11.5 % of the post-
transfer group reported 20 years and older as the most pre-
ferred age to transfer to AHC.
Discussion
Few differences were reported about barriers to successful
transition to AHC between the groups before and after
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transfer. The extent of similarities in the pre- and post-transfer
groups provides evidence that the perceived barriers by young
people prior to transfer are not simply the result of anxiety
about the upcoming changes. Rather, it highlights the signif-
icance of this event for young people and the need for greater
attention to this issue.
Most important barriers to successful transition The most
important barrier reported by both groups was feeling at ease
with the pediatrician, although this was more frequently rated
among young people who had not yet transferred. Given the
long-term relationship that young people with a chronic con-
dition (and their parents) develop with their pediatrician and
care team, the perceived importance of this relationship is not
surprising as a barrier to leaving pediatric health care and
engaging with AHC services. This is consistent with Reiss
et al. who suggest that an appropriately planned termination of
pediatric relationships should be part of the transition process
[32]. Barriers are typically thought to be preventable or at least
modifiable. In this case, knowing the value of feeling at ease
with the pediatrician underlines the importance of individual
pediatricians helping the young person establish a trusting
relationship with the AHC provider, for example, by
supporting young people develop self-management skills
and by ensuring that young people have sufficient information
about the AHC provider and the AHC service.
Table 1 Sample characteristics
of patients, pre-transfer and post-
transfer
Pre-transfer (n=283) Post-transfer (n=89) p value
n (%) or mean (SD) n (%) or mean (SD)
Age (years) 16.3 (±2.2) 19.7 (±2.3) n.a.
Gender (% female) 157 (55.5) 39 (43.8) 0.06
Recruiting hospital 0.07
Lausanne 103 (36.4) 42 (47.2)
Zurich 180 (63.6) 47 (52.8)
Duration of chronic disorder (years) 9.0 (±5.6) 13.0 (±6.3) n.a.
Participants with a congenital disorder 60 (21.3) 31 (35.3) 0.06
Self-perceived health status (very good to excellent) 140 (49.3) 44 (48.9) 0.95
Missed school/work past month (≥1 day/month) 65 (22.9) 21 (24.1) 0.81
Hospitalization in past 12 months (≥1) 71 (25.1) 18 (20.2) 0.35
Table 2 Comparison of barriers and most preferred age to transfer between young people, pre- and post-transfer
Bivariate analysis Multivariate analysis
Pre-transfer (n=283) Post-transfer (n=89) Pre-/post-transfer (n=372)
n (%) 95 %CI n (%) 95 %CI Adjusted OR 95 %CI p value
Most important barrier to successful transfer
Feeling at ease with the pediatrician 136 (47.7) 42.2–53.8 29 (32.1) 21.7–42.5 2.03a 1.12–3.71 0.02a
Anxiety 61 (21.6) 16.8–26.4 25 (28.6) 18.2–39.0 0.67a 0.35–1.28 0.23a
Lack of information 56 (19.7) 15.1–24.3 21 (23.8) 13.4–34.2 0.71a 0.36–1.38 0.31a
Parent’s preferenceb 4 (1.4) 0.0–2.8 8 (9) 3.1–15.0 0.15a 0.04–0.58 0.006a
Most preferred age to transfer to AHC
15 years and younger 10 (3.7) 1.5–5.9 5 (5.7) 0.0–16.1 0.55c 0.10–2.97 0.49c
16–17 years 87 (30.7) 25.3–36.1 38 (42.5) 32.1–52.9 0.55c 0.22–1.38 0.20c
18–19 years 146 (51.5) 46.2–57.8 36 (40.2) 29.8–50.6 1.07c 0.44–2.59 0.89c
20 years and older 40 (14.2) 10.0–18.0 10 (11.5) 1.1–21.9 1.00d
a Logistic regression; odds ratios, and p values for pre-transfer/post-transfer after having controlled for gender, congenital disorder, health status,
recruiting hospital, and specialty
b Parent’s preference as perceived by the young person
cMultinomial regression; odds ratios, and p values for pre-transfer/post-transfer after having controlled for gender, congenital disorder, health status,
recruiting hospital, and specialty
d Reference category
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Lack of information and anxiety were equally important
barriers for young people before and after transfer. Our results
show that anxiety was in part related to lack of information,
but it was also caused by specific fears such as potentially
different therapies in AHC, loss of information about the
patient’s condition during the transfer process, and nonspecif-
ic anxiety about the transfer to AHC. Anxiety was not statis-
tically correlated with age. This finding in our non-disease-
specific sample confirms the results of Boyle et al. in their
study of young people with cystic fibrosis which showed that
neither age, gender, nor severity of lung disease was predictive
of the level of concern about transfer to AHC [7]. Lack of
information has been previously identified as a barrier to
successful transition in a number of studies with smaller
sample size and/or qualitative study design [8, 11, 25, 30,
44] which is confirmed in our larger quantitative study that
utilized a generic rather than disease-specific approach. It is
notable that the post-transfer respondents equally complained
about lack of information. This suggests that the pre-transfer
group’s perception of lack of information is not just caused by
anxiety or due to the transition process being still in progress.
Our finding of lack of information confirms preliminary evi-
dence in the existing literature that provision of information
during the transition process needs to be optimized [8, 11, 30].
A positive attitude by young people about the transfer process
has been reported [46]. However, it is important that pediatri-
cians do not interpret a “wait and see” attitude as a sign of
transition readiness per se. Providing opportunities for young
people to meet staff from the AHC service prior to transfer,
such as joint consultations with both the pediatric team and the
AHC team, has the potential to reduce anxiety and transition
concerns, as shown in several studies. For example, Boyle
et al. reported a reduction in transition concerns after intro-
ducing the AHC team to cystic fibrosis patients prior to
transfer to AHC [7]. Similarly, in a qualitative study of 22
adolescents with chronic illness, of whom one third trans-
ferred to AHC during the study period, participants suggested
that earlier discussions about transition, opportunities to meet
the adult care team, and visits to the adult-oriented services
prior to transition might have aided their transition process
[14, 41, 43]. Introduction of the AHC team and/or location has
also been perceived as important by others [40]. In our recent
publication focusing on perceptions of adolescents and their
parents prior to transfer to AHC, 48 % of adolescents and
57% of parents reported that joint meetings with pediatric and
adult health professionals would facilitate transfer to AHC
[35]. Interestingly, Chaudhry et al. showed that while their
structured transition program for patients with cystic fibrosis
did not decrease patient anxiety during the transition period, it
seemed to improve patient satisfaction, perceived health sta-
tus, and patient independence [12]. This suggests that equip-
ping young people with the skills that support self-
management would enable them to better negotiate AHC
and could be expected to help reduce anxiety both
before and after transfer. As reported in a study of
954 patients aged 12–19 years with chronic conditions,
48 % of the variance in transition readiness was explained
by perceived self-efficacy in skills for independent hospital
visits, perceived independence during consultations, attitude
towards transition, and having had more frequent discussions
regarding transition [45].
Most preferred age to transfer to AHC Despite consensus
statements recommending that the transition process should
start several years before the actual transfer to AHC [2, 34],
only half of the pre-transfer adolescents indicated that their
pediatrician had ever talked to them about the transition to
AHC and only 10 % of the post-transfer respondents recalled
that their first discussion about transition to AHC had hap-
pened before the age of 16 years. This suggests that there is
much room for improvement in Swiss clinical practices, con-
sistent with other studies that show that discussions with
patients and parents start too late. For example, McLaughlin
et al. showed in post-transfer patients with cystic fibrosis that
initial discussion of transition did not start until 2 years before
transfer, which provides limited time for development of the
necessary self-care skills [27]. Providing more detailed infor-
mation about the transition process on a regular basis, includ-
ing addressing adolescent anxieties and transition concerns,
and supporting the acquisition of self-management skills
should start early during the transitional process, several years
before the transfer to AHC [2, 26, 47], and should also
continue after transfer to AHC.
Different ages have been suggested for transfer to AHC.
Sixteen and 18 years have been most frequently proposed
based on historical norms around health-care systems in dif-
ferent countries [33]. In our study, more than 80 % of the
respondents in both groups reported that 16–19 years was the
most preferred age to transfer to AHC; more than half of all
the respondents in each group perceived the ages of 18–
19 years and older as the most preferred age to transfer.
Perhaps not surprisingly, given the high reports of anxiety
and lack of information, more young people who had not
yet transferred to AHC preferred a slightly higher age of
transfer (18–19 years) compared to those who had already
transferred, who equally preferred 16–17 and 18–19 years.
However, national pediatric health-care regulations in many
countries do not allow continued access to pediatric health
care once young people turn 16 (i.e., access to pediatric care is
restricted for those older than 15 years). Ercan et al. showed
that 12 out of 29 European countries have an official upper age
limit of 16 years for access to pediatric inpatient care; six of
these countries restrict access to 14 years [18]. The two
recruiting Swiss pediatric hospitals in this study allow patients
with chronic disorders to be transferred to AHC beyond
15 years of age, with the mean age at time of transfer being
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18.1 years in the post-transfer group. This may help explain
the relatively high percentage (72 %) of post-transfer respon-
dents who felt ready at the time they transferred. However,
even in Switzerland, the upper age limit for access to pediatric
hospitals varies from hospital to hospital, between subspe-
cialties at the same hospital, and between outpatient and
inpatient services. Access to pediatric services is even more
reduced for young people without a chronic illness. Perhaps
one reason for this confusing situation is that the historical
upper age limit of 16 years (i.e., access to pediatric hospitals
up to 15 years) has not yet officially been changed. This
contrasts with young people’s preferences, as only 3.7 % of
the pre-transfer respondents and 5.7 % of the post-transfer
respondents preferred below 16 years as the most preferred
age to transfer. Effectively, this suggests that only around 5 %
of young people support the current upper age policies of the
12 European countries with pediatric access restricted beyond
15 years of age.
There is some evidence that higher age at transfer increases
the rate of successful transfer to AHCwith potential effects on
health outcomes. A study of young people with congenital
heart disease reported that transferring at a later age was
associated with more successful transition, resulting in more
timely consultations in AHC [31]. Similarly, a large study of
pediatric renal transplant recipients showed that the graft
failure rate was 58 % higher in patients who transferred to
AHC before the age of 21 years compared to those who
transferred at an older age [19]. In another study, again with
renal transplant recipients, while no increase in allograft loss
was observed during the transition period, patients were trans-
ferred to AHC between the ages of 18 and 20 years [22].
Beyond chronological age, timing for transfer to AHC should
also take psychosocial maturation and personal circumstances
into account. Thus, within a certain age range, the most
preferred age to transfer may vary between individuals with
the same condition. Additional assessment of transition read-
iness, based on self-management efficacy and advocacy skills,
could be a more effective way to promote successful transition
to AHC than solely relying on chronological age [15, 32, 33,
42, 45].
Cultural differences may also be of significance when
exploring patient expectations with regard to the most pre-
ferred age to transfer and transfer readiness. For example, in
contrast to European hospitals, the upper age limit for patients
in pediatric care in the USA is 21 years [13, 24], with transi-
tion clinics and adolescent clinics being available in many
large pediatric hospitals. Despite these cultural differences, the
perception of our Swiss participants did not vary much from
US young people in regard to the most preferred age to
transfer [7]. In contrast, transfer to AHC between 15 and
17 years of age was perceived as normal in a small qualitative
study of adolescents who attended a pediatric cardiology
clinic in Belgiumwhere the standard transfer age was 16 years
[29]. Further studies are required to investigate whether and
how much national upper age regulations influence young
people’s expectations about the age to transfer to AHC.
Amajor concern in this study was the reduced frequency of
consultations with the specialist doctor and general practi-
tioners after transfer to AHC. Low frequency of specialist
consultations in AHC will obviously make it more difficult
for the transferred patient to establish a trusting relationship
with the adult specialist, and especially when associated with
reduced primary care visits as in this study also threatens
adherence with medication. It is disappointing how consistent
these results are with other studies [8, 11, 21]. One exception
is a French multisite study of patients with cystic fibrosis that
reported increased outpatient visits in the year after transition
[17]. This may reflect more consistent health-care delivery
between the pediatric and adult cystic fibrosis services as
reflected by shared clinical practice guidelines. Alternatively,
it might reflect greater patient self-efficacy (e.g., to make
clinical appointments), as the mean age of transfer was
21.6 years which is much older than inmost European centers.
This is consistent with studies that show continued brain
maturation well beyond the age of 20 years that could be
expected to be associated with higher self-efficacy [10].
A strength of the study was that the non-disease-specific
(generic) recruitment strategy enabled a relatively large sam-
ple to be recruited. This study also has a number of limitations.
Firstly, the cross-sectional nature prevents any conclusion
regarding causality. A longitudinal cohort study would be
ideal at tracking how the opinions of individual patients vary
as they traverse the transition years and how these opinions
might be influenced by different approaches to transition
within their clinics. The long duration required for such a
study was beyond our available resources. Secondly, general-
izability is limited as the results are based on two Swiss
pediatric university hospitals and may not be representative
of pediatric health care more widely. However, these two
pediatric hospitals are among the largest pediatric hospitals
in Switzerland and are most likely comparable to specialized
pediatric health care in many other high-income countries
with regard to the transition from pediatric to ACH. Thirdly,
no conclusions can be drawn about the transition approach of
the two recruiting pediatric hospitals, as different transition
models were utilized by different subspecialties across the two
hospitals. Ideally, a randomized controlled trial comparing
younger and older age at transition or testing different models
of transition support within either pediatric or AHC could start
to address some of the wider questions raised within this
study.
The improved survival of adolescents with previously fatal
conditions provides a challenge to both pediatric and adult
health-care systems to provide more adolescent friendly health
care, including older age of transfer to AHC [1, 36, 37]. Our
results of young people’s preferences, when taken with recent
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evidence that suggests that higher age at transfer is associated
with better health outcomes and less anxiety, endorse the need
for a more carefully planned, developmentally appropriate
approach to transfer to AHC. In terms of timing, there is little
rationale for pediatric hospitals to transfer adolescents prior to
16 years of age and much greater rationale to transfer adoles-
cents to AHC after the age of 18 years.
In conclusion, this study suggests that more successful
transition to AHC could be achieved by greater attention to
transition planning, especially through interventions that help
adolescents build trust with the adult health-care provider, that
provides greater information and reduces anxiety.
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